Plasma CellsMultiple MyelomaBone MarrowParaproteinemiasBone Marrow CellsBone Marrow TransplantationPrognosisFlow CytometryTransplantation, HomologousParaproteinsB-LymphocytesBone and BonesGraft vs Host DiseaseTransplantation, AutologousAmyloidosisWhole-Body IrradiationAnemia, AplasticBone Marrow DiseasesHematopoietic Stem CellsLeukemiaHematopoietic Stem Cell TransplantationBone Marrow PurgingTransplantation ConditioningBone Marrow ExaminationTransplantation ChimeraBone RemodelingBone Marrow NeoplasmsGraft SurvivalLiver TransplantationTissue DonorsBusulfanHematopoiesisMice, Inbred C57BLHistocompatibility TestingCyclophosphamideHistocompatibilityLeukemia, Plasma CellNondisjunction, GeneticBone DensityRadiation ChimeraTime FactorsLeukemia, Myeloid, AcuteRecurrenceCombined Modality TherapyBone ResorptionKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell DifferentiationColony-Forming Units AssayTreatment OutcomeRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic NeoplasmsImmunosuppressive AgentsLeukemia, MyeloidGraft RejectionT-LymphocytesHepatic Veno-Occlusive DiseaseLymphocyte DepletionAcute DiseaseGraft vs Host ReactionLymphoma, Non-HodgkinStem Cell TransplantationImmunosuppressionMyelodysplastic SyndromesTransplantation ImmunologySpleenCells, CulturedBone NeoplasmsChimeraLeukocyte TransfusionNeoplasms, Plasma CellSurvival AnalysisSevere Combined ImmunodeficiencyPancytopeniaMice, Inbred BALB CRetrospective StudiesHematologic DiseasesBone DevelopmentBone DiseasesHLA AntigensHeart TransplantationLeukocyte CountAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34ImmunophenotypingGranulocyte Colony-Stimulating FactorMice, KnockoutCyclosporineGranulocytesLymphocyte TransfusionActuarial AnalysisStromal CellsMelphalanAngiolymphoid Hyperplasia with EosinophiliaCell SeparationFollow-Up StudiesLung TransplantationCarmustineNuclear Family